CMS on Tuesday proposed making its new Medicare Part D 340B data repository mandatory for covered entities—nine months after finalizing [...] …
Providers
Drug purchases under the 340B program reached a record $100 billion in 2025, marking a 23% increase over the $81.4 [...] …
Please Login or Become a Paid Subscriber to View this Content
A new potential 340B rebate pilot, drugmaker 340B in-house pharmacy claims data requirements and new congressional reform proposals dominated discussions [...] …
Please Login or Become a Paid Subscriber to View this Content
Provider and drug manufacturer groups are continuing to schedule high-stakes meetings with White House officials in an effort to influence [...] …
Please Login or Become a Paid Subscriber to View this Content
Two national 340B provider groups asked a federal judge Monday for permission to join HRSA in defending the agency’s 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
340B provider advocates and attorneys warned this week that a new Trump administration proposed rule overhauling the federal grant process [...] …
Please Login or Become a Paid Subscriber to View this Content
A bipartisan U.S. House bill that would pause drug manufacturer 340B rebates, establish a new patient definition and create contract [...] …
Please Login or Become a Paid Subscriber to View this Content
Hospital groups slammed CMS’ recent proposal to slash Medicare Part B payments for 340B drugs, while a private oncologist group [...] …
Please Login or Become a Paid Subscriber to View this Content
Four major drugmakers recently renewed their push to dismiss a California health system’s 340B overcharge whistleblower lawsuit—just months after a [...] …
Please Login or Become a Paid Subscriber to View this Content
AHA recently announced that it has selected the head of a Massachusetts hospital trade group to take over as its [...] …